Medicines360 Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2009
NCT00995150
First Marketed Drug
2015
norgestrel (Ovral)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medicines360 | MEDICINES360

Active Ingredients

Marketed Drugs (1)

norgestrel (Ovral) (2015)

Drugs in Phase 3 Trials (2)

levonorgestrel (1 trial)

norgestrel (Ovral) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Menorrhagia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2